Cargando…
Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer
Wee1 is a member of the Serine/Threonine protein kinase family and is a key regulator of cell cycle progression. It has been known that WEE1 is highly expressed and has oncogenic functions in various cancers, but it is not yet studied in gastric cancers. In this study, we investigated the oncogenic...
Autores principales: | Kim, Hye-Young, Cho, Yunhee, Kang, HyeokGu, Yim, Ye-Seal, Kim, Seok-Jun, Song, Jaewhan, Chun, Kyung-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226556/ https://www.ncbi.nlm.nih.gov/pubmed/27363019 http://dx.doi.org/10.18632/oncotarget.10231 |
Ejemplares similares
-
Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer
por: Cho, Yunhee, et al.
Publicado: (2015) -
Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy
por: Esposito, Francesca, et al.
Publicado: (2021) -
Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
por: Bukhari, Amirali B., et al.
Publicado: (2022) -
Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
por: Lee, Yoo-Young, et al.
Publicado: (2019) -
Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain
por: Kang, Hyeok Gu, et al.
Publicado: (2016)